| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.54 | 0.009 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.52 | 0.002 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.43 | 0.02 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.37 | 0.08 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.34 | 0.1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.34 | 0.09 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.28 | 4e-06 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.26 | 0.2 |